Skip to main content
. 2019 Aug 19;6(4):521–528. doi: 10.1007/s40744-019-00171-w

Fig. 1.

Fig. 1

Rate of PsA patients (n = 80) achieving VLDA and DAPSA remission for at least one time and for a sustained (> 12 months) period